NOL9

NOL9 (the human ortholog of yeast Grc3) is a nucleolar polynucleotide 5'-kinase that drives the ITS2-processing arm of large ribosomal subunit biogenesis (PMID:21063389, PMID:23175604). It assembles with the Las1L (yeast Las1) endoribonuclease into a higher-order tetrameric kinase–endonuclease complex, within which Las1 cleaves the pre-rRNA at the C2 site while NOL9 phosphorylates the resulting RNA ends; the two enzymes reciprocally activate one another, and NOL9 kinase activity is directed preferentially toward single-stranded RNA over DNA substrates (PMID:28652339, PMID:29440475). NOL9 contributes a nucleolar localization sequence that targets the assembled complex to the nucleolus, providing spatial control over ITS2 cleavage (PMID:31288032). Loss of NOL9 kinase function blocks generation of 5.8S and 28S rRNAs from the 32S precursor and produces a 5' maturation defect at the 5.8S short form consistent with a requirement for 5'→3' exonucleolytic trimming (PMID:21063389). In yeast, the kinase additionally governs RNA polymerase I transcription termination by controlling the phosphorylation state of the Rnt1 cleavage product and thereby its accessibility to the Rat1 torpedo exonuclease (PMID:20814424). Disruption of NOL9-dependent rRNA maturation engages the p53 surveillance axis: zebrafish nol9 loss impairs hematopoietic and pancreatic progenitor proliferation in part through Tp53 (PMID:26624285), and pharmacological severing of the LAS1–NOL9 interaction mislocalizes LAS1 to the cytoplasm and activates the NPM1–MDM2–p53 pathway (PMID:36796466).

1. 2010 High

   Establishing that NOL9 is an enzyme and not merely a structural factor answered what biochemical activity it contributes to ribosome assembly, identifying it as a polynucleotide 5'-kinase needed to make mature large-subunit rRNAs.

   Evidence in vitro kinase assay plus siRNA depletion with sucrose gradients and Northern blotting in HeLa cells

   PMID:21063389

   Open questions at the time

   • Direct RNA substrate and exact phosphorylation site within the pre-rRNA not defined
   • Functional partner mediating coupling to cleavage not yet identified
2. 2010 High

   Parallel yeast work answered how the kinase fits into transcription control, placing Grc3 upstream of the Rat1 torpedo exonuclease in RNA polymerase I termination via phosphorylation of the Rnt1 cleavage product.

   Evidence yeast genetics, in vitro kinase assay, ChIP and transcription run-on in S. cerevisiae

   PMID:20814424

   Open questions at the time

   • Whether the human ortholog performs the same termination role not tested
   • Direct phosphorylation of the termination substrate not shown structurally
3. 2012 High

   Identifying Grc3 as a major Las1 partner answered which pathway the kinase operates in, showing shared rRNA intermediate accumulation that places the two proteins in the same pre-60S processing route.

   Evidence co-IP, conditional depletion, kinase-dead mutant analysis and Northern blotting in S. cerevisiae

   PMID:23175604

   Open questions at the time

   • Stoichiometry and architecture of the complex not resolved
   • Order of cleavage versus phosphorylation events not established
4. 2017 High

   Reconstitution answered how cleavage and phosphorylation are mechanistically linked, revealing a tetrameric complex in which Grc3 programs Las1 for C2 cleavage and Las1 reciprocally activates Grc3 toward single-stranded RNA.

   Evidence in vitro reconstitution of kinase and endonuclease assays with mutagenesis and in vivo cleavage assays in S. cerevisiae

   PMID:28652339

   Open questions at the time

   • High-resolution structure of the human complex not determined
   • How the complex selects the C2 site within ITS2 not fully defined
5. 2018 High

   Defining substrate preference and active-site requirements answered whether the kinase activity itself is essential for cleavage, showing RNA-over-DNA selectivity and active-site residues required to support Las1-mediated cleavage in vivo.

   Evidence in vitro kinase assays with RNA/DNA substrates, active-site mutagenesis and in vivo pre-rRNA processing in S. cerevisiae

   PMID:29440475

   Open questions at the time

   • Physiological 5'-phosphorylated product fate downstream not tracked
   • Coupling mechanism at atomic resolution not resolved
6. 2019 High

   Mapping the human complex answered how it reaches its site of action, demonstrating that NOL9 supplies the nucleolar localization sequence that imports the assembled Las1L–NOL9 complex into the nucleolus.

   Evidence co-IP, deletion mapping, electron microscopy and NoLS mutational fluorescence microscopy in human cells

   PMID:31288032

   Open questions at the time

   • Sub-nucleolar dynamics during the cell cycle not characterized
   • Regulation of complex assembly versus import not separated
7. 2011 Medium

   Fission yeast work extended the role beyond rRNA, linking Grc3 to heterochromatic silencing and to the IPI complex via Swi6/Clr4-dependent localization.

   Evidence co-IP, conditional mutants, cytology, Northern blotting and silencing reporters in S. pombe

   PMID:21385875

   Open questions at the time

   • Whether the human ortholog has any silencing function untested
   • Mechanistic link between rRNA processing and heterochromatin localization unclear
8. 2015 Medium

   Vertebrate loss-of-function answered the physiological consequence of NOL9 deficiency, showing tissue-specific progenitor proliferation defects with a Tp53-dependent hematopoietic component and Tp53-independent pancreatic component.

   Evidence zebrafish nol9 mutant with Northern blot, tp53 epistasis and mTOR pathway intervention

   PMID:26624285

   Open questions at the time

   • Molecular basis of the Tp53-independent pancreatic mechanism unknown
   • Direct relevance to human disease not established in this study
9. 2023 Medium

   Pharmacological disruption answered whether the LAS1–NOL9 interaction is a tractable node, showing that severing it mislocalizes LAS1 to the cytoplasm, blocks 28S maturation and activates the NPM1–MDM2–p53 axis.

   Evidence covalent compound HEN-463 with site-specific binding, fractionation, rRNA maturation and p53 Western blot in AML cells

   PMID:36796466

   Open questions at the time

   • Direct on-target effect of disrupting NOL9 specifically versus LAS1 not separated
   • Generality across cancer types not established
10. 2025 Medium

    Cancer-context regulation answered how NOL9 expression is controlled and what downstream proliferative pathway it engages, linking DNMT1/ZNF384-mediated regulation to Wnt/β-catenin-dependent proliferation in HCC.

    Evidence DNA methylation analysis, ZNF384 regulation assays, knockdown/overexpression, xenograft growth and Wnt pathway Western blot in HCC cells

    PMID:39955289

    Open questions at the time

    • Mechanistic link between NOL9 ribosome biogenesis function and Wnt signaling unresolved
    • Whether the effect requires NOL9 kinase activity not tested

• How NOL9's rRNA-processing activity is mechanistically connected to the diverse downstream outputs (p53 surveillance, Wnt signaling, heterochromatin) and whether these require its kinase activity remain open.
• No structure of the human Las1L–NOL9 complex
• Causal chain from impaired ITS2 processing to Wnt activation unmapped
• Human-specific termination and silencing roles untested